This article is more than 5 years old. Information may no longer be current.

Allergan posts 13.3% rise in first-quarter product sales

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

IRVINE, Calif. — Allergan reported $1.25 billion in total product sales for the first quarter, up 13.3% from the same period last year, according to a company press release.

Allergan reported a 13.3% increase in specialty pharmaceutical total net sales and a 13% increase in medical device total net sales compared with sales totals in the first quarter of 2010, the release said.

The company's board of directors also reported a first-quarter dividend of $0.05 per share, which will be payable to stockholders on June 10.

"Sales growth was based on a broad range of products and geographies, and was further boosted by the launches of products and indications approved in 2010, a record year for regulatory approvals, positioning us for strong growth in the medium term," David E.I. Pyott, Allergan's chairman of the board, president and CEO, said in the release.